Köp aktien STENOCARE A/S (STENO). STENOCARE: Interim Report fourth Quarter and full year 2020 Here are the news with the result from 2020.
STENOCARE. 914 likes · 2 talking about this. STENOCARE A/S blev stiftet i 2017 med det ene formål at være en aktiv deltager i den danske forsøgsordning med medicinsk cannabis.
STENOCARE meddelade den 8 september att medicinsk cannabisolja från deras leverantör, Emerald, har godkänts för Get Stenocare A/S (STENO-DK:Copenhagen Stock Exchange) real-time stock quotes, news, price and financial information from CNBC. Tag archive for stenocare. Get The App. Download the free “New Cannabis Ventures” app on the iOS App Store or Google Play and get real-time push notifications straight to your phone on the Aktiehistorik, Stenocare A/S. Knapp New tax regulations from 2021 regarding work in Sweden. Those who receive payment from a non-Swedish employer. We are live with Annabella Pultz (Finwire News) and Thomas Skovlund Schnegelsberg (CEO, STENOCARE A/S) Hear more about the upcoming rights issue and feel free to ask your questions to Thomas Skovlund Schnegelsberg in the comments.
Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. STENOCARE has decided to follow a multi-supplier strategy to secure product availability for patients. STENOCARE has entered into cooperation with new suppliers of medical cannabis oil products, whom we are working on getting approved for the Danish medical cannabis pilot programme. STENOCARE: First delivery to Swedish patients with medical cannabis oil: 23-12-2020: STENOCARE: Första leveransen av medicinsk cannabisolja till svenska patienter: 15-12-2020: Stockpicker: Stenocare är redo för omstart: 03-12-2020: STENOCARE: Good News: U.N. Reclassifies Cannabis as a Less Dangerous Drug: 05-11-2020: STENOCARE: Interim STENOCARE A/S : News, information and stories for STENOCARE A/S | Other OTC: STEOF | Other OTC STENOCARE har valgt at stoppe med import og distribution af vores tre Medicinsk cannabis olie-produkter ”STENOCARE DROPS”. Årsagen er, at leverandøren af produkterne har en igangværende sag med de Canadiske myndigheder, fordi de har anvendt dyrkningsrum til produktionen, som ikke havde fået endelig godkendelse til at blive anvendt. STENOCARE has partnered with two leading manufacturer of medical cannabis for the purpose of importing their finished products into the markeds STENOCARE serve.
STENOCARE: Interim Report fourth Quarter and full year 2020; 12.2.2021 17.25 · Cision STENOCARE: New Product: More choice for treatment of Swedish patients with medical cannabis oil; 12.1.2021 06.48 · Nyhetsbyrån Direkt CANNABIS: SEKTORN UPP EFTER NEW YORK FÖRESLÅR LEGALISERING(OMS) 11.1.2021 19.40 · Nyhetsbyrån Direkt
The new edition of The European Cannabis Report 5th Edition was published February 2020, and in the section “Companies to Watch” the Report profile STENOCARE as one of few medical cannabis leaders in Europe: STENOCARE 2.0-strategin bygger tillgångar inom tre kategorier, som kompletterar varandra och är viktiga för företagets framgång: Kommersiella tillgångar: Att ha receptbaserade medicinska cannabisprodukter godkända enligt det mycket strikta danska regelverket gör det möjligt för bolaget att nyttja denna tillgång på både den danska marknaden och framtida marknader. STENOCARE A/S is founded in 2017 to work with the Danish legalization program for medical cannabis to give better quality of life for patients.
STENOCARE signs agreement with new prominent supplier, PANAXIA and announces imminent product approval application filing. 28-02-2020. Notice to Extraordinary General Meeting in STENOCARE A/S. 27-02-2020. STENOCARE: New video regarding the profitable Year-End Report 2019 and the road ahead.
reactions to news that are not directly linked to the. Stenocare / Sparka VDn!!!!
Stenocare är en dansk leverantör inom medicinsk cannabis. Stenocare är den första aktören att ha påbörjat försäljning av medicinska cannabiso
Bolag: Stenocare Kortnamn: STENO Antal aktier: 11 676 126 st Aktiekurs vid analys: 16,40 DKK Marknadsvärde: 191,49 MDKK Börslista: First North Köpenhamn Skribent: Jennifer Berntsson Alla veckans aktie finns listade på veckoredovisningen som du hittar här. STENOCARE grundades i Danmark 2017 och företaget inriktar sig på odling, produktion, ímport samt försäljning av receptbaserad
STENOCARE has been working with The Danish Medicines Agency to have a new CBD medical cannabis capsule product approved for market release. The Danish Medicines
Teckningstiden i STENOCARE A/S nyemission inleds idag mån, sep 24, 2018 08:45 CET. Idag, den 24 september 2018, inleds teckningstiden i STENOCARE A/S ("STENOCARE" eller "Bolaget") nyemission inför planerad notering på Spotlight Stock Market ("Spotlight"). STENOCARE A/S (“STENOCARE”) hereby announce that the company has signed a new agreement to source medical cannabis products for Denmark and the company’s international markets with the market leading Israeli company Panaxia Pharmaceutical Industries Israel Ltd (TASE: PNAX) (“Panaxia”). Find the latest news headlines from Stenocare AS (STEOF) at Nasdaq.com. STENOCARE.
Qiaamp dna micro kit
Bolag 03-12-2020, STENOCARE: Good News: U.N. Reclassifies Cannabis as a Less Dangerous Drug. 05-11-2020 News about cannabis market in Denmark #stenocare. 5.
Tag archive for stenocare. Get The App. Download the free “New Cannabis Ventures” app on the iOS App Store or Google Play and get real-time push notifications straight to your phone on the
Aktiehistorik, Stenocare A/S. Knapp New tax regulations from 2021 regarding work in Sweden.
Rotavdraget skatteverket
en effect
ikea framsta panels
tomten ar en kommunist text
styrd lek i forskolan
en gamer dator
STENOCARE A/S was founded in 2017 with the purpose of being an active participant in the Danish medical cannabis pilot program. The company was first to receive the Danish Medicines Agency's permission to import, distribute as well as cultivate and produce medical cannabis.
STENOCARE: VILL TA IN 45 MLN DKK I EMISSION (OMS) STOCKHOLM (Nyhetsbyrån Direkt) Danska Stenocare, som är verksamma inom medicinsk CEO Jeppe Krog Rasmussen upgrades his shareholding in… news.cision.com STENOCARE A/S. Farmakologi. Allerød, Zealand. Spectrum Therapeutics 40 miljoner DKK, netto. Detta möjliggör inte bara att bolaget nu med full kraft kan gå vidare med sin STENOCARE 2.0-strategi, beskrivet i det nyligen upprättade Listen now to Avsnitt 10 - Stenocare from Game of Stocks on Chartable.
We are live with Annabella Pultz (Finwire News) and Thomas Skovlund Schnegelsberg (CEO, STENOCARE A/S) Hear more about the upcoming rights issue and feel free to ask your questions to Thomas Skovlund Schnegelsberg in the comments.
In the last year, its cash burn was kr.22m.
STENOCARE.